Literature DB >> 11104776

Protein kinase C activation modulates alpha-calmodulin kinase II binding to NR2A subunit of N-methyl-D-aspartate receptor complex.

F Gardoni1, C Bellone, F Cattabeni, M Di Luca.   

Abstract

The N-methyl-d-aspartate (NMDA) receptor subunits NR2 possess extended intracellular C-terminal domains by which they can directly interact with a large number of postsynaptic density (PSD) proteins involved in synaptic clustering and signaling. We have previously shown that PSD-associated alpha-calmodulin kinase II (alphaCaMKII) binds with high affinity to the C-terminal domain of the NR2A subunit. Here, we show that residues 1412-1419 of the cytosolic tail of NR2A are critical for alphaCaMKII binding, and we identify, by site directed mutagenesis, PKC-dependent phosphorylation of NR2A(Ser(1416)) as a key mechanism in inhibiting alphaCaMKII-binding and promoting dissociation of alphaCaMKII.NR2A complex. In addition, we show that stimulation of PKC activity in hippocampal slices either with phorbol esters or with the mGluRs specific agonist trans-1-amino-1,3- cyclopentanedicarboxylic acid (t-ACPD) decreases alphaCaMKII binding to NMDA receptor complex. Thus, our data provide clues on understanding the molecular basis of a direct cross-talk between alphaCaMKII and PKC pathways in the postsynaptic compartment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104776     DOI: 10.1074/jbc.M009922200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Telling tails.

Authors:  M B Kennedy; P Manzerra
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

Review 2.  Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II.

Authors:  Andy Hudmon; Howard Schulman
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

3.  Protein kinase CK2 increases glutamatergic input in the hypothalamus and sympathetic vasomotor tone in hypertension.

Authors:  Zeng-You Ye; De-Pei Li; Li Li; Hui-Lin Pan
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

Review 4.  Participation of CaMKII in neuronal plasticity and memory formation.

Authors:  Martín Cammarota; Lia R M Bevilaqua; Haydée Viola; Daniel S Kerr; Bruno Reichmann; Viviane Teixeira; Mário Bulla; Iván Izquierdo; Jorge H Medina
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

Review 5.  Signaling cascades regulating NMDA receptor sensitivity to ethanol.

Authors:  Dorit Ron
Journal:  Neuroscientist       Date:  2004-08       Impact factor: 7.519

6.  N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons.

Authors:  Csaba Vastagh; Fabrizio Gardoni; Vincenza Bagetta; Jennifer Stanic; Elisa Zianni; Carmen Giampà; Barbara Picconi; Paolo Calabresi; Monica Di Luca
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

7.  Loss of F-box only protein 2 (Fbxo2) disrupts levels and localization of select NMDA receptor subunits, and promotes aberrant synaptic connectivity.

Authors:  Graham Atkin; Shannon Moore; Yuan Lu; Rick F Nelson; Nathan Tipper; Gautam Rajpal; Jack Hunt; William Tennant; Johannes W Hell; Geoffrey G Murphy; Henry Paulson
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

Review 8.  Modulation of NMDA receptors in the cerebellum. 1. Properties of the NMDA receptor that modulate its function.

Authors:  Marta Llansola; Ana Sanchez-Perez; Omar Cauli; Vicente Felipo
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

Review 9.  Synaptic plasticity and phosphorylation.

Authors:  Hey-Kyoung Lee
Journal:  Pharmacol Ther       Date:  2006-08-14       Impact factor: 12.310

10.  Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.

Authors:  Yan Chen; Cheng Yang; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.